YRDCP1

Across TCGA pan-cancer cohorts, YRDCP1 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of YRDCP1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where YRDCP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types YRDCP1 is over-expressed in tumor, although a few such as KIRP show the opposite, repressed pattern.

COAD, HNSC, and STAD are the cancer types where YRDCP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in YRDCP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.172	.001	5	view →
HNSC	All	All	+0.035	.025	5	view →
STAD	All	All	+0.266	.013	4	view →
UCEC	All	IV	+0.305	.012	2	view →
BRCA	Female	All	+0.108	.029	2	view →
LUSC	Male	All	+0.105	.029	2	view →
PRAD	All	All	+0.088	.006	2	view →
KIRP	Male	III,IV	−0.070	.018	2	view →
LIHC	Female	All	+0.036	.041	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

YRDCP1–COAD

Open the COAD breakdown →